Tarsons Products

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE144Z01023
  • NSEID: TARSONS
  • BSEID: 543399
INR
224.75
-3.85 (-1.68%)
BSENSE

Dec 05

BSE+NSE Vol: 33.29 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003569,
    "name": "Tarsons Products",
    "stock_name": "Tarsons Products",
    "full_name": "Tarsons Products Ltd",
    "name_url": "stocks-analysis/tarsons-products",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "224.75",
    "chg": -3.85,
    "chgp": "-1.68%",
    "dir": -1,
    "prev_price": "228.60",
    "mcapval": "1,195.81 Cr",
    "mcap": "Small Cap",
    "scripcode": 543399,
    "symbol": "TARSONS",
    "ind_name": "Healthcare Services",
    "ind_code": 40,
    "indexname": "",
    "isin": "INE144Z01023",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "33.29 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/tarsons-products-1003569-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Tarsons Products overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-tarsons-products-overvalued-or-undervalued-3739964",
        "imagepath": "",
        "date": "2025-12-02 08:21:51",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Understanding Tarsons Products’ Valuation Metrics</strong></p>\n<p>As of 1 December 2025, Tarsons Products exhibits a price-to-earnings (PE) ratio of 59.3, signalling a premium valuation relative to earnings. This is considerably higher than many of its peers, although some competitors in the healthcare services space command even loftier multiples. The price-to-book (P/B) ratio stands at 1.94, suggesting the stock trades nearly twice its book value, which is moderate but still indicative of investor confidence in the company’s asset utilisation.</p>\n<p>Enterprise value (EV) multiples further illustrate the valuation landscape. The EV to EBIT ratio is notably elevated at 40.7, while EV to EBITDA is 13.3, reflecting expectations of strong operational cash flow generation despite modest profita..."
      },
      {
        "title": "Tarsons Products Sees Revision in Market Evaluation Amidst Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tarsons-products-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3737188",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TarsonsProducts_mojoScore_3737188.png",
        "date": "2025-11-30 10:24:23",
        "description": "Tarsons Products, a small-cap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment follows a period marked by subdued profitability, rising leverage, and persistent underperformance relative to broader market benchmarks."
      },
      {
        "title": "Tarsons Products Hits Intraday High with Strong 8.75% Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tarsons-products-hits-intraday-high-with-875-surge-on-25-nov-2025-3729107",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TarsonsProducts_priceRelatedfactors_3729107.png",
        "date": "2025-11-25 13:52:23",
        "description": "Tarsons Products demonstrated a robust intraday performance on 25 Nov 2025, surging to an intraday high of Rs 220.1, reflecting an 8.75% gain over the previous close. This notable uptick marks a reversal after a prolonged period of decline, positioning the stock as a standout performer within the Healthcare Services sector today."
      },
      {
        "title": "Tarsons Products Hits Intraday Low Amid Price Pressure and Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tarsons-products-hits-intraday-low-amid-price-pressure-on-24-nov-2025-3725695",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TarsonsProducts_priceRelatedfactors_3725695.png",
        "date": "2025-11-24 14:18:36",
        "description": "Tarsons Products experienced a significant intraday decline on 24 Nov 2025, touching a new 52-week and all-time low of ₹198.7. The stock faced notable price pressure, underperforming its sector and the broader market amid heightened volatility and a prolonged downward trend."
      },
      {
        "title": "Tarsons Products Falls to 52-Week Low of Rs.198.7 Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tarsons-products-stock-falls-to-52-week-low-of-rs1987-amid-continued-downtrend-3725223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TarsonsProducts_priceRelatedfactors_3725223.png",
        "date": "2025-11-24 11:05:21",
        "description": "Tarsons Products has reached a new 52-week low of Rs.198.7, marking a significant decline amid sustained downward pressure. The stock has experienced a continuous fall over the past 16 trading sessions, reflecting ongoing challenges within the healthcare services sector."
      },
      {
        "title": "Tarsons Products Falls to 52-Week Low of Rs.198.7 Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tarsons-products-stock-falls-to-52-week-low-of-rs1987-amid-continued-downtrend-3725218",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TarsonsProducts_priceRelatedfactors_3725218.png",
        "date": "2025-11-24 11:05:19",
        "description": "Tarsons Products has reached a new 52-week low of Rs.198.7, marking a significant decline amid a sustained period of negative returns and heightened volatility. The stock’s recent performance contrasts sharply with broader market trends, underscoring ongoing challenges within the company’s financial metrics and market positioning."
      },
      {
        "title": "Tarsons Products Falls to 52-Week Low of Rs.198.7 Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tarsons-products-stock-falls-to-52-week-low-of-rs1987-amid-continued-downtrend-3725224",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TarsonsProducts_priceRelatedfactors_3725224.png",
        "date": "2025-11-24 11:05:19",
        "description": "Tarsons Products, a player in the Healthcare Services sector, has reached a new 52-week low of Rs.198.7, marking a significant milestone in its ongoing price decline. The stock has experienced a sustained downward trajectory over the past several weeks, reflecting a series of financial and market challenges."
      },
      {
        "title": "Tarsons Products Stock Falls to 52-Week Low of Rs.198.7 Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tarsons-products-stock-falls-to-52-week-low-of-rs1987-amidst-prolonged-downtrend-3725219",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TarsonsProducts_priceRelatedfactors_3725219.png",
        "date": "2025-11-24 11:05:19",
        "description": "Tarsons Products has reached a new 52-week low of Rs.198.7 today, marking a significant decline amid a sustained downward trend that has extended over the past 16 trading sessions. The stock’s performance contrasts sharply with broader market gains, reflecting ongoing pressures within the healthcare services sector."
      },
      {
        "title": "Tarsons Products Falls to 52-Week Low of Rs.198.7 Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tarsons-products-stock-falls-to-52-week-low-of-rs1987-amid-continued-downtrend-3725220",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TarsonsProducts_priceRelatedfactors_3725220.png",
        "date": "2025-11-24 11:05:17",
        "description": "Tarsons Products, a key player in the Healthcare Services sector, has reached a new 52-week low of Rs.198.7, marking a significant decline amid a sustained downward trend. The stock has experienced a notable period of losses, reflecting ongoing pressures within the company’s financial performance and market positioning."
      }
    ],
    "total": 197,
    "sid": "1003569",
    "stock_news_url": "https://www.marketsmojo.com/news/tarsons-products-1003569"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "28-Nov-2025",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mitsubishi UFJ Financial Group (MUFG) & First Sentier Investors (Hong Kong) Ltd",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Further Investment In Tarsons Life Science Pte. Ltd. A Wholly-Owned Subsidiary Of The Company.",
      "datetime": "27-Nov-2025",
      "details": "Further investment in Tarsons Life Science Pte. Ltd. a wholly Owned Subsidiary of the Company in Singapore to repay loans and other operational & financial obligations.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "19-Nov-2025",
      "details": "Transcript of Earning Conference Call for the quarter ended September 30 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Tarsons Products Ltd has declared <strong>100%</strong> dividend, ex-date: 20 Sep 24",
          "dt": "2024-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Is Tarsons Products overvalued or undervalued?

2025-12-02 08:21:51

Understanding Tarsons Products’ Valuation Metrics

As of 1 December 2025, Tarsons Products exhibits a price-to-earnings (PE) ratio of 59.3, signalling a premium valuation relative to earnings. This is considerably higher than many of its peers, although some competitors in the healthcare services space command even loftier multiples. The price-to-book (P/B) ratio stands at 1.94, suggesting the stock trades nearly twice its book value, which is moderate but still indicative of investor confidence in the company’s asset utilisation.

Enterprise value (EV) multiples further illustrate the valuation landscape. The EV to EBIT ratio is notably elevated at 40.7, while EV to EBITDA is 13.3, reflecting expectations of strong operational cash flow generation despite modest profita...

Read More
stock-recommendationAnnouncement

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

28-Nov-2025 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mitsubishi UFJ Financial Group (MUFG) & First Sentier Investors (Hong Kong) Ltd

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Further Investment In Tarsons Life Science Pte. Ltd. A Wholly-Owned Subsidiary Of The Company.

27-Nov-2025 | Source : BSE

Further investment in Tarsons Life Science Pte. Ltd. a wholly Owned Subsidiary of the Company in Singapore to repay loans and other operational & financial obligations.

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

19-Nov-2025 | Source : BSE

Transcript of Earning Conference Call for the quarter ended September 30 2025

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Tarsons Products Ltd has declared 100% dividend, ex-date: 20 Sep 24

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available